DDrare: Database of Drug Development for Rare Diseases

Butyrate (DrugBank: Butyrate)

2 diseases

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	1
291	Hirschsprung disease, entire colon type	1

97. Ulcerative colitis [ 2,269 clinical trials, 1,331 drugs, (DrugBank: 241 drugs), 114 drug target genes, 181 drug target pathways]

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,269 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04259060 (ClinicalTrials.gov)	June 2020	27/1/2020	Hydroxocobalamin Approach to Reduction of Calprotectin With Butyrate for Ulcerative Colitis Research	Hydroxocobalamin Approach to Reduction of Nitrite With Butyrate for Ulcerative Colitis	Ulcerative Colitis	Drug: Hydroxocobalamin with Butyrate;Drug: Placebo with Butyrate	Joshua Korzenik	NULL	Not yet recruiting	18 Years	75 Years	All	42	Phase 2	United States

291. Hirschsprung disease, entire colon type [ 13 clinical trials, 32 drugs, (DrugBank: 15 drugs), 0 drug target gene, 0 drug target pathway]

Searched query = "Hirschsprung disease, entire colon type", "Hirschsprung disease, small intestine type", "Hirschsprung disease", "Hirschprung disease", "Hirschsprung disease associated entercolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 13 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03660176 (ClinicalTrials.gov)	January 2, 2019	4/9/2018	Effects of Butyrate Enemas on Postoperative Intestinal Mobility Disorders in Hirschsprung's Disease	Effects of Butyrate Enemas on Postoperative Intestinal Mobility Disorders in Hirschsprung's	Hirschsprung's Disease	Drug: butyrate enemas + routine management;Other: routine management	Assistance Publique Hopitaux De Marseille	NULL	Not yet recruiting	N/A	17 Years	All	58	Phase 3	France